Investors Capital Advisory Services’s Novo Nordisk NVO Stock Holding History

Investors Capital Advisory Services’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.98M	Sell	110,892 -4,640	-4%	-$127K	0.57%	26
2016 Q1	$3.13M	Buy	115,532 +23,598	+26%	+$632K	0.62%	26
2015 Q4	$2.67M	Sell	91,934 -3,746	-4%	-$104K	0.52%	32
2015 Q3	$2.59M	Sell	95,680 -5,132	-5%	-$145K	0.52%	30
2015 Q2	$2.76M	Buy	100,812 +5,852	+6%	+$165K	0.51%	29
2015 Q1	$2.53M	Buy	94,960 +1,564	+2%	+$36K	0.47%	29
2014 Q4	$1.98M	Buy	93,396 +14,646	+19%	+$327K	0.38%	47
2014 Q3	$1.87M	Sell	78,750 -29,206	-27%	-$672K	0.37%	51
2014 Q2	$2.49M	Buy	107,956 +30,694	+40%	+$678K	0.4%	46
2014 Q1	$1.76M	Buy	77,262 +22,252	+40%	+$474K	0.38%	50
2013 Q4	$1.02M	Sell	55,010 -65,460	-54%	-$1.14M	0.24%	121
2013 Q3	$2.04M	Sell	120,470 -24,470	-17%	-$412K	0.53%	32
2013 Q2	$2.25M	Buy	+144,940	New	+$2.41M	0.68%	22

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Investors Capital Advisory Services's NVO Position: Q2 2016 in Review

Investors Capital Advisory Services reduced its Novo Nordisk (NVO) stake by 4% in Q2 2016, selling an estimated $127K and leaving 110,892 shares worth $2.98M. The position accounts for 0.57% of the portfolio, ranked #26.

Investors Capital Advisory Services first reported a position in NVO in Q2 2013 and has held it in 13 quarters since. The position peaked at $3.13M in Q1 2016. 530 funds tracked by Wall St. Rank hold NVO as of Q2 2016.

Investors Capital Advisory Services held 110,892 shares of Novo Nordisk worth $2.98M as of Q2 2016.
Investors Capital Advisory Services sold 4,640 Novo Nordisk shares in Q2 2016, an estimated $127K.
Novo Nordisk made up 0.57% of Investors Capital Advisory Services's portfolio in Q2 2016, its #26 holding.
Investors Capital Advisory Services first reported a position in Novo Nordisk in Q2 2013 and has held it in 13 quarters since.
Investors Capital Advisory Services's Novo Nordisk position peaked at $3.13M in Q1 2016.
530 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2016.

Based on Investors Capital Advisory Services's 13F filing for Q2 2016, filed 2 Aug 2016.